Marqeta (MQ) director reports RSU exercise and 52,219-unit equity grant
Rhea-AI Filing Summary
Marqeta director Martha Cummings reported routine equity compensation activity. She exercised 36,297 restricted stock units into the same number of Class A Common shares, bringing her direct Class A holdings to 66,707 shares. She also received a new grant of 52,219 restricted stock units that each convert into one Class A share and vest in full on the earlier of June 10, 2027 or Marqeta’s next annual stockholder meeting, subject to continued service.
Positive
- None.
Negative
- None.
Insights
Routine director equity grant and RSU vesting, no buy/sell signal.
Martha Cummings, a director of Marqeta, exercised 36,297 restricted stock units into Class A Common Stock and received a new award of 52,219 restricted stock units. These transactions are compensation-related and exempt from Section 16(b), not open-market trades.
The prior RSU award granted in June 2025 vested in full on June 10, 2026, aligning director compensation with shareholder outcomes around annual meetings. With 66,707 Class A shares held directly and an unvested grant outstanding, her equity exposure to Marqeta remains meaningful.
Because there were no open-market purchases or sales, and no derivative positions remain after the exercise, the filing mainly updates her ownership profile. Subsequent company filings may provide further context on overall director compensation structure and any future grants.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 36,297 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 52,219 | $0.00 | -- |
| Exercise | Class A Common Stock | 36,297 | $0.00 | -- |
Footnotes (1)
- Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. Each restricted stock unit is convertible into one share of Class A Common Stock. Restricted stock units granted on June 12, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, that vested in full on June 10, 2026, the date of the Issuer's 2026 Annual Meeting of Stockholders. All of the shares vest in full on the earlier of (i) June 10, 2027 or (ii) the Issuer's next annual meeting of stockholders; provided, however, that all vesting will cease if the Reporting Person ceases to provide services to the Issuer, unless the Issuer's Board of Directors determines otherwise prior to the cessation of such services.